glp 1 and ibd GLPs as novel therapeutic options in IBD-potential mechanisms of action Small peptide encoded by MALAT1

For me, this is intriguing and promising science

We see you in person

"It's good news that Medicare is rolling out this program, but it is temporary, so it's really not clear at this point what happens after the end of the 18-month program duration," said Juliette Cubanski, director of the Program on Medicare Policy at KFF, a health policy research organization

Diabetes Metab Res Rev 35(7):e3168 Fernndez-Ruiz I (2024) SELECT shows cardiovascular risk reduction with weight-loss drug semaglutide in people without diabetes

This makes you feel full longer AND reduces glucose in the bloodstream, lowering blood sugar

We may recommend slower dose increases if you have existing eye disease